Tweet
SAN JOSE, Calif.,/NEW YORK (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.
More...
More...
Hi All
For those boardites who are facebook we have a Boardite Facebook Group. Be sure to check it out.